Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System

Jorge Cortes, Michael Mauro, Juan Luis Steegmann, Giuseppe Saglio, Rachpal Malhotra, Jon A. Ukropec, Nicola T. Wallis

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System'. Together they form a unique fingerprint.

Medicine & Life Sciences